Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020944

« Back to Dashboard

NDA 020944 describes JUNIOR STRENGTH ADVIL, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. Additional details are available on the JUNIOR STRENGTH ADVIL profile page.

The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for 020944

Tradename:	JUNIOR STRENGTH ADVIL
Applicant:	Pfizer
Ingredient:	ibuprofen
Patents:	0
Therapeutic Class:	Analgesics Anti-inflammatory Agents
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 020944

Analgesics, Non-Narcotic
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors

Suppliers and Packaging for NDA: 020944

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CHILDREN'S ADVIL	ibuprofen	TABLET, CHEWABLE;ORAL	020944	NDA	Pfizer Consumer Healthcare	0573-0179	N	0573-0179-20
JUNIOR STRENGTH ADVIL	ibuprofen	TABLET, CHEWABLE;ORAL	020944	NDA	Pfizer Consumer Healthcare	0573-0179	N	0573-0179-20

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	TABLET, CHEWABLE;ORAL			Strength	50MG
Approval Date:	Dec 18, 1998	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	OTC	Dosage:	TABLET, CHEWABLE;ORAL			Strength	100MG
Approval Date:	Dec 18, 1998	TE:		RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys

Daiichi Sankyo

Citi

Mallinckrodt

McKesson

Johnson and Johnson

AstraZeneca

Cantor Fitzgerald

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.